Literature DB >> 12870062

The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers.

Luiz C Arraes1, Ricardo Ximenes, Jean-Marie Andrieu, Wei Lu, Silvana Barreto, Leila M M B Pereira, Adauto Castelo.   

Abstract

In order to assess the potential risk of anti-HBc-positive blood donors for post-transfusional hepatitis and to investigate whether other HBV serological markers are capable of identifying the presence of the virus, 1000 first-time blood donors were enrolled between June and July 1997. These donors were screened using routine Brazilian blood center tests (HIV 1 and 2, HTLV 1 and 2, Chagas disease, Syphilis, HCV, HBsAg, anti-HBc and ALT ). The 120 (12%) found to be anti-HBc-positive underwent further tests: HBe, anti-HBe, anti-HBs and HBV-DNA by PCR. Ten cases were HBsAg positive and all were HBV-DNA positive by PCR. Three HBsAg-negative donors were HBV-DNA-positive. Two HBV-DNA-positive donors were also anti-HBs-positive. All the HBV-positive donors had at least one HBV marker other than anti-HBc. Anti-HBc is an important cause of blood rejection. Testing for HBsAg alone is not fully protective and anti-HBc remains necessary as a screening test. The presence of anti-HBs is not always indicative of absence of the virus. The addition of other HBV serological markers could represent an alternative in predicting the presence of the virus when compared with PCR. It is recommended that other studies should be carried out to confirm this finding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870062     DOI: 10.1590/s0036-46652003000300004

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  4 in total

1.  Screening for hepatitis B virus infection in Egyptian blood donors negative for hepatitis B surface antigen.

Authors:  Assem M El-Sherif; Mohamed A Abou-Shady; Mohsen A Al-Hiatmy; Ashraf M Al-Bahrawy; Elham A Motawea
Journal:  Hepatol Int       Date:  2007-09-15       Impact factor: 6.047

Review 2.  Hepatitis B virus management to prevent reactivation after chemotherapy: a review.

Authors:  Jessica P Hwang; John M Vierling; Andrew D Zelenetz; Susan C Lackey; Rohit Loomba
Journal:  Support Care Cancer       Date:  2012-08-30       Impact factor: 3.603

3.  Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy.

Authors:  M N dos S Moresco; H de A Virgolino; M P E de Morais; I da Motta-Passos; M S Gomes-Gouvêa; L M S de Assis; K R de L Aguiar; S C F Lombardi; A Malheiro; N de P Cavalheiro; J E Levi; K L Torres
Journal:  Vox Sang       Date:  2014-02-21       Impact factor: 2.144

4.  Occult hepatitis B virus infection among blood donors in Colombia.

Authors:  Wilson Alfredo Rios-Ocampo; Fabián Cortes-Mancera; Juan Camilo Olarte; Angela Soto; Maria-Cristina Navas
Journal:  Virol J       Date:  2014-11-29       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.